Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd. 6821.HK Peers
See (6821.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6821.HK | HK$70.70 | -3.68% | 33.7B | 23.03 | HK$3.07 | +2.56% |
| 1801.HK | HK$72.30 | -2.63% | 119.3B | -1032.86 | -HK$0.07 | N/A |
| 2269.HK | HK$24.90 | -1.19% | 101.3B | 29.29 | HK$0.85 | N/A |
| 1177.HK | HK$4.53 | -1.95% | 81B | 41.18 | HK$0.11 | +1.32% |
| 9926.HK | HK$81.95 | +0.99% | 73.5B | -126.08 | -HK$0.65 | N/A |
| 1530.HK | HK$19.44 | -1.02% | 45.8B | 20.90 | HK$0.93 | +1.29% |
| 3759.HK | HK$15.76 | -2.48% | 43.5B | 13.70 | HK$1.15 | +1.64% |
| 1877.HK | HK$21.40 | -6.14% | 32.2B | -13.81 | -HK$1.55 | N/A |
| 9688.HK | HK$28.55 | +5.35% | 31.4B | -12.98 | -HK$2.20 | N/A |
| 2096.HK | HK$12.26 | -1.92% | 30.5B | 38.31 | HK$0.32 | +1.43% |
Stock Comparison
6821.HK vs 1801.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1801.HK has a market cap of 119.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1801.HK trades at HK$72.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1801.HK's P/E ratio is -1032.86. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1801.HK's ROE of -0.01%. Regarding short-term risk, 6821.HK is more volatile compared to 1801.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2269.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2269.HK has a market cap of 101.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2269.HK trades at HK$24.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2269.HK's P/E ratio is 29.29. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2269.HK's ROE of +0.06%. Regarding short-term risk, 6821.HK is more volatile compared to 2269.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1177.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1177.HK has a market cap of 81B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1177.HK trades at HK$4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1177.HK's P/E ratio is 41.18. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1177.HK's ROE of +0.11%. Regarding short-term risk, 6821.HK is more volatile compared to 1177.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9926.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9926.HK has a market cap of 73.5B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9926.HK trades at HK$81.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9926.HK's P/E ratio is -126.08. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9926.HK's ROE of -0.09%. Regarding short-term risk, 6821.HK is more volatile compared to 9926.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1530.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1530.HK has a market cap of 45.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1530.HK trades at HK$19.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1530.HK's P/E ratio is 20.90. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1530.HK's ROE of +0.14%. Regarding short-term risk, 6821.HK is more volatile compared to 1530.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 3759.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 3759.HK has a market cap of 43.5B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 3759.HK trades at HK$15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 3759.HK's P/E ratio is 13.70. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 3759.HK's ROE of +0.14%. Regarding short-term risk, 6821.HK is more volatile compared to 3759.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1877.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1877.HK has a market cap of 32.2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1877.HK trades at HK$21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1877.HK's P/E ratio is -13.81. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1877.HK's ROE of -0.20%. Regarding short-term risk, 6821.HK is less volatile compared to 1877.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9688.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9688.HK has a market cap of 31.4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9688.HK trades at HK$28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9688.HK's P/E ratio is -12.98. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9688.HK's ROE of -0.33%. Regarding short-term risk, 6821.HK is more volatile compared to 9688.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2096.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2096.HK has a market cap of 30.5B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2096.HK trades at HK$12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2096.HK's P/E ratio is 38.31. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2096.HK's ROE of +0.10%. Regarding short-term risk, 6821.HK is less volatile compared to 2096.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9995.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9995.HK has a market cap of 30.4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9995.HK trades at HK$47.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9995.HK's P/E ratio is -15.93. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9995.HK's ROE of -0.58%. Regarding short-term risk, 6821.HK is more volatile compared to 9995.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1548.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1548.HK has a market cap of 28.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1548.HK trades at HK$13.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1548.HK's P/E ratio is -21.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1548.HK's ROE of -0.06%. Regarding short-term risk, 6821.HK is more volatile compared to 1548.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2696.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2696.HK has a market cap of 24.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2696.HK trades at HK$45.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2696.HK's P/E ratio is 27.71. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2696.HK's ROE of +0.29%. Regarding short-term risk, 6821.HK is more volatile compared to 2696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6855.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6855.HK has a market cap of 19.1B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6855.HK trades at HK$54.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6855.HK's P/E ratio is -37.64. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6855.HK's ROE of -0.79%. Regarding short-term risk, 6821.HK is more volatile compared to 6855.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9969.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9969.HK has a market cap of 17.1B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9969.HK trades at HK$11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9969.HK's P/E ratio is -40.86. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9969.HK's ROE of -0.06%. Regarding short-term risk, 6821.HK is more volatile compared to 9969.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1952.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1952.HK has a market cap of 15.4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1952.HK trades at HK$47.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1952.HK's P/E ratio is -13.44. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1952.HK's ROE of -0.24%. Regarding short-term risk, 6821.HK is more volatile compared to 1952.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2162.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2162.HK has a market cap of 12.7B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2162.HK trades at HK$45.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2162.HK's P/E ratio is -21.37. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2162.HK's ROE of -0.20%. Regarding short-term risk, 6821.HK is more volatile compared to 2162.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6826.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6826.HK has a market cap of 11.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6826.HK trades at HK$26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6826.HK's P/E ratio is 13.42. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6826.HK's ROE of +0.07%. Regarding short-term risk, 6821.HK is more volatile compared to 6826.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2171.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2171.HK has a market cap of 10.9B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2171.HK trades at HK$19.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2171.HK's P/E ratio is -12.14. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2171.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 2171.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 0775.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 0775.HK has a market cap of 8.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 0775.HK trades at HK$0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 0775.HK's P/E ratio is -89.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 0775.HK's ROE of -0.03%. Regarding short-term risk, 6821.HK is more volatile compared to 0775.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9966.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9966.HK has a market cap of 7.7B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9966.HK trades at HK$8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9966.HK's P/E ratio is 44.61. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9966.HK's ROE of +0.10%. Regarding short-term risk, 6821.HK is more volatile compared to 9966.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2157.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2157.HK has a market cap of 7.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2157.HK trades at HK$4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2157.HK's P/E ratio is -17.69. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2157.HK's ROE of -0.51%. Regarding short-term risk, 6821.HK is less volatile compared to 2157.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2315.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2315.HK has a market cap of 7.4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2315.HK trades at HK$17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2315.HK's P/E ratio is 196.44. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2315.HK's ROE of -0.19%. Regarding short-term risk, 6821.HK is more volatile compared to 2315.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1672.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1672.HK has a market cap of 7.2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1672.HK trades at HK$7.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1672.HK's P/E ratio is -23.39. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1672.HK's ROE of -0.15%. Regarding short-term risk, 6821.HK is less volatile compared to 1672.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2142.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2142.HK has a market cap of 6.7B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2142.HK trades at HK$7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2142.HK's P/E ratio is 263.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2142.HK's ROE of +0.02%. Regarding short-term risk, 6821.HK is less volatile compared to 2142.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2256.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2256.HK has a market cap of 6.2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2256.HK trades at HK$9.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2256.HK's P/E ratio is 229.50. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2256.HK's ROE of +0.01%. Regarding short-term risk, 6821.HK is less volatile compared to 2256.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1477.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1477.HK has a market cap of 6.2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1477.HK trades at HK$7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1477.HK's P/E ratio is -17.90. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1477.HK's ROE of -0.08%. Regarding short-term risk, 6821.HK is more volatile compared to 1477.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2616.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2616.HK has a market cap of 5.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2616.HK trades at HK$3.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2616.HK's P/E ratio is -49.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2616.HK's ROE of -0.22%. Regarding short-term risk, 6821.HK is more volatile compared to 2616.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1541.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1541.HK has a market cap of 5.2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1541.HK trades at HK$13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1541.HK's P/E ratio is -14.44. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1541.HK's ROE of -0.49%. Regarding short-term risk, 6821.HK is less volatile compared to 1541.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6660.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6660.HK has a market cap of 4.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6660.HK trades at HK$3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6660.HK's P/E ratio is -15.80. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6660.HK's ROE of -0.08%. Regarding short-term risk, 6821.HK is more volatile compared to 6660.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1167.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1167.HK has a market cap of 4.1B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1167.HK trades at HK$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1167.HK's P/E ratio is -23.41. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1167.HK's ROE of -0.17%. Regarding short-term risk, 6821.HK is more volatile compared to 1167.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2179.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2179.HK has a market cap of 4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2179.HK trades at HK$8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2179.HK's P/E ratio is -6.59. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2179.HK's ROE of -0.82%. Regarding short-term risk, 6821.HK is more volatile compared to 2179.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1873.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1873.HK has a market cap of 3.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1873.HK trades at HK$1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1873.HK's P/E ratio is 25.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1873.HK's ROE of +0.04%. Regarding short-term risk, 6821.HK is more volatile compared to 1873.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2487.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2487.HK has a market cap of 3.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2487.HK trades at HK$10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2487.HK's P/E ratio is -6.99. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2487.HK's ROE of -0.40%. Regarding short-term risk, 6821.HK is less volatile compared to 2487.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2509.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2509.HK has a market cap of 3.1B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2509.HK trades at HK$14.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2509.HK's P/E ratio is -8.10. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2509.HK's ROE of -1.12%. Regarding short-term risk, 6821.HK is less volatile compared to 2509.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 3681.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 3681.HK has a market cap of 2.8B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 3681.HK trades at HK$2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 3681.HK's P/E ratio is -13.11. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 3681.HK's ROE of -0.79%. Regarding short-term risk, 6821.HK is less volatile compared to 3681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6996.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6996.HK has a market cap of 2.4B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6996.HK trades at HK$3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6996.HK's P/E ratio is -6.59. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6996.HK's ROE of -0.35%. Regarding short-term risk, 6821.HK is less volatile compared to 6996.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1521.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1521.HK has a market cap of 2.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1521.HK trades at HK$1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1521.HK's P/E ratio is 56.50. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1521.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 1521.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2181.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2181.HK has a market cap of 2B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2181.HK trades at HK$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2181.HK's P/E ratio is -16.17. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2181.HK's ROE of -1.25%. Regarding short-term risk, 6821.HK is more volatile compared to 2181.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6978.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6978.HK has a market cap of 1.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6978.HK trades at HK$3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6978.HK's P/E ratio is -8.18. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6978.HK's ROE of -0.01%. Regarding short-term risk, 6821.HK is less volatile compared to 6978.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6622.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6622.HK has a market cap of 1.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6622.HK trades at HK$2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6622.HK's P/E ratio is -6.30. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6622.HK's ROE of -0.12%. Regarding short-term risk, 6821.HK is less volatile compared to 6622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1875.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1875.HK has a market cap of 1.6B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1875.HK trades at HK$1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1875.HK's P/E ratio is 39.20. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1875.HK's ROE of +0.05%. Regarding short-term risk, 6821.HK is more volatile compared to 1875.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2137.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2137.HK has a market cap of 1.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2137.HK trades at HK$1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2137.HK's P/E ratio is -2.42. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2137.HK's ROE of -0.18%. Regarding short-term risk, 6821.HK is more volatile compared to 2137.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6998.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6998.HK has a market cap of 1.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6998.HK trades at HK$2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6998.HK's P/E ratio is -23.09. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6998.HK's ROE of -0.05%. Regarding short-term risk, 6821.HK is less volatile compared to 6998.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2511.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2511.HK has a market cap of 1.3B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2511.HK trades at HK$2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2511.HK's P/E ratio is -2.81. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2511.HK's ROE of -0.00%. Regarding short-term risk, 6821.HK is less volatile compared to 2511.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1244.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1244.HK has a market cap of 1.1B. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1244.HK trades at HK$4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1244.HK's P/E ratio is -5.23. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1244.HK's ROE of -0.22%. Regarding short-term risk, 6821.HK is more volatile compared to 1244.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2496.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2496.HK has a market cap of 820M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2496.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2496.HK's P/E ratio is -7.83. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2496.HK's ROE of -3.00%. Regarding short-term risk, 6821.HK is more volatile compared to 2496.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2126.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2126.HK has a market cap of 765.6M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2126.HK trades at HK$1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2126.HK's P/E ratio is -1.18. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2126.HK's ROE of -0.45%. Regarding short-term risk, 6821.HK is more volatile compared to 2126.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2185.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2185.HK has a market cap of 718.9M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2185.HK trades at HK$3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2185.HK's P/E ratio is -7.82. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2185.HK's ROE of -0.13%. Regarding short-term risk, 6821.HK is less volatile compared to 2185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6628.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 6628.HK has a market cap of 685.2M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 6628.HK trades at HK$1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 6628.HK's P/E ratio is -1.94. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6628.HK's ROE of -0.35%. Regarding short-term risk, 6821.HK is less volatile compared to 6628.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9939.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 9939.HK has a market cap of 620.9M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 9939.HK trades at HK$1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 9939.HK's P/E ratio is -3.67. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9939.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is less volatile compared to 9939.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 0690.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 0690.HK has a market cap of 506.4M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 0690.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 0690.HK's P/E ratio is 8.10. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 0690.HK's ROE of +0.26%. Regarding short-term risk, 6821.HK is more volatile compared to 0690.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2257.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2257.HK has a market cap of 388.1M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2257.HK trades at HK$3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2257.HK's P/E ratio is -0.71. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2257.HK's ROE of +71.56%. Regarding short-term risk, 6821.HK is more volatile compared to 2257.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2197.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 2197.HK has a market cap of 298.7M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 2197.HK trades at HK$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 2197.HK's P/E ratio is -0.31. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2197.HK's ROE of +0.73%. Regarding short-term risk, 6821.HK is more volatile compared to 2197.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 8158.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 8158.HK has a market cap of 109.5M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 8158.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 8158.HK's P/E ratio is 6.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 8158.HK's ROE of +0.71%. Regarding short-term risk, 6821.HK is less volatile compared to 8158.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1228.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 33.7B. In comparison, 1228.HK has a market cap of 61.6M. Regarding current trading prices, 6821.HK is priced at HK$70.70, while 1228.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 23.03, whereas 1228.HK's P/E ratio is -0.13. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1228.HK's ROE of +1.17%. Regarding short-term risk, 6821.HK is more volatile compared to 1228.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.